Therefore, in addition to transcriptional activation, it was suggested that the apparent upregulation of NOXA in MM cells after BTZ plus CAM treatment appeared to be due to the concomitant inhibition of proteasomes with BTZ and autophagy with CAM (Fig 3A). This evidence concerns the gene PMAIP1 and Miyoshi myopathy.